| Basics |
Exact Sciences Corporation
Exact Sciences Corp operates in the healthcare sector. It is a diagnostics company focused on the early detection and prevention of colorectal cancer.
|
| IPO Date: |
January 31, 2001 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$12.7B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.76 | 2.69%
|
| Avg Daily Range (30 D): |
$0.86 | 1.36%
|
| Avg Daily Range (90 D): |
$0.93 | 1.76%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.23M |
| Avg Daily Volume (30 D): |
2.27M |
| Avg Daily Volume (90 D): |
2.49M |
| Trade Size |
| Avg Trade Size (Sh.): |
100 |
| Avg Trade Size (Sh.) (30 D): |
58 |
| Avg Trade Size (Sh.) (90 D): |
64 |
| Institutional Trades |
| Total Inst.Trades: |
19,816 |
| Avg Inst. Trade: |
$3.15M |
| Avg Inst. Trade (30 D): |
$3.4M |
| Avg Inst. Trade (90 D): |
$3.11M |
| Avg Inst. Trade Volume: |
.05M |
| Avg Inst. Trades (Per Day): |
6 |
| Market Closing Trades |
| Avg Closing Trade: |
$10.36M |
| Avg Closing Trade (30 D): |
$15.98M |
| Avg Closing Trade (90 D): |
$16.44M |
| Avg Closing Volume: |
179.84K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$-.1
|
$-.01
|
|
Diluted EPS
|
|
$-.1
|
$-.01
|
|
Revenue
|
$
|
$ 850.74M
|
$ 811.09M
|
|
Gross Profit
|
$
|
$ 583.93M
|
$ 562.45M
|
|
Net Income / Loss
|
$
|
$ -19.59M
|
$ -1.19M
|
|
Operating Income / Loss
|
$
|
$ -25.55M
|
$ -2.15M
|
|
Cost of Revenue
|
$
|
$ 266.81M
|
$ 248.63M
|
|
Net Cash Flow
|
$
|
$ 131.94M
|
$ 309.97M
|
|
PE Ratio
|
|
|
|
|
|
|
